Discordance between clinical and immunological ART eligibility criteria for children in Malawi

[1]  D. Milner,et al.  Discordance between clinical and immunological ART eligibility criteria for children in Malawi , 2014, BMC Research Notes.

[2]  M. Egger,et al.  Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old. , 2013, The Cochrane database of systematic reviews.

[3]  Arrow trial team.  Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial , 2013 .

[4]  A. Walker,et al.  Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial , 2013, The Lancet.

[5]  Gundo Weiler,et al.  Global Update on HIV Treatment 2013: Results, Impact and Opportunities , 2013 .

[6]  Kami Kim,et al.  HIV in the tropics: staging in the resource-limited setting , 2012, Current opinion in infectious diseases.

[7]  E. Diggle,et al.  CD4 testing at clinics to assess eligibility for antiretroviral therapy. , 2012, Malawi medical journal : the journal of Medical Association of Malawi.

[8]  Indi Trehan,et al.  Challenges in the Management of HIV-Infected Malnourished Children in Sub-Saharan Africa , 2012, AIDS research and treatment.

[9]  E. Katabira,et al.  Validation of World Health Organisation HIV/AIDS Clinical Staging in Predicting Initiation of Antiretroviral Therapy and Clinical Predictors of Low CD4 Cell Count in Uganda , 2011, PloS one.

[10]  Nick Fowler,et al.  Towards Universal Access , 2010 .

[11]  P. Kazembe,et al.  Discontinuation of standard first-line antiretroviral therapy in a cohort of 1434 Malawian children , 2010, Journal of the International AIDS Society.

[12]  J. Crump,et al.  Total Lymphocyte Count and World Health Organization Pediatric Clinical Stage as Markers to Assess Need to Initiate Antiretroviral Therapy Among Human Immunodeficiency Virus-Infected Children in Moshi, Northern Tanzania , 2009, The Pediatric infectious disease journal.

[13]  R. Colebunders,et al.  Initiating antiretroviral treatment in a resource-constrained setting: does clinical staging effectively identify patients in need? , 2009, International journal of STD & AIDS.

[14]  F. Behets,et al.  Computed CD4 percentage as a low-cost method for determining pediatric antiretroviral treatment eligibility , 2008, BMC infectious diseases.

[15]  H. Zar,et al.  Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis , 2008, AIDS.

[16]  Julian Gold,et al.  Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. , 2007 .